Evidence map›Paper›PMID 34517830›Full record

ArticleBMC infectious diseases2021

Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain.

R Matulionytė, M L Jakobsen, V I Grecu, J Grigaitiene, T Raudonis, L Stoniene, M Olteanu, L de la Mora, D Raben, A K Sullivan

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 5 countries.

R MatulionytėDepartment of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Vilnius University, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
M L JakobsenDepartment of Infectious Diseases, CHIP, Rigshospitalet, Copenhagen, Denmark. marie.louise.jakobsen@regionh.dk.ORCID http://orcid.org/0000-0002-6436-8993
V I GrecuVictor Babes' Clinical Hospital of Infectious Diseases and Pneumophtisiology, Craiova, Romania.
J GrigaitieneDepartment of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Vilnius University, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
T RaudonisDepartment of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Vilnius University, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
L StonieneRepublican Centre for Addictive Disordes, Giedraičių g. 8, LT-03147, Lithuania, Kaunas, Lithuania.
M OlteanuVictor Babes' Clinical Hospital of Infectious Diseases and Pneumophtisiology, Craiova, Romania.
L de la MoraHIV Clinic, Hospital Clinic Barcelona, Barcelona, Spain.
D RabenDepartment of Infectious Diseases, CHIP, Rigshospitalet, Copenhagen, Denmark.
A K SullivanChelsea & Westminster Hospital NHS Foundation Trust, London, UK.
Vilnius University · LTRigshospitalet · DKSpitalul Clinic Dr. Victor Babes · ROChelsea and Westminster Hospital NHS Foundation Trust · GBHospital Clínic de Barcelona · ESLithuanian Social Research Centre · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndicator condition guided HIV testing is a proven effective strategy for increasing HIV diagnosis in health care facilities. As part of the INTEGRATE Joint Action, we conducted four pilot studies, aiming to increase integrated testing for HIV/HCV/HBV and sexually transmitted infections, by introducing and expanding existing indicator condition guided HIV testing methods.

methodsPilot interventions included combined HIV/HCV testing in a dermatovenerology clinic and a clinic for addictive disorders in Lithuania; Increasing HIV testing rates in a tuberculosis clinic in Romania by introducing a patient information leaflet and offering testing for HIV/HCV/sexually transmitted infections to chemsex-users in Barcelona. Methods for implementing indicator condition guided HIV testing were adapted to include integrated testing. Testing data were collected retrospectively and prospectively. Staff were trained in all settings, Plan-do-study-act cycles frequently performed and barriers to implementation reported.

resultsIn established indicator conditions, HIV absolute testing rates increased from 10.6 to 71% in the dermatovenerology clinic over an 18 months period. HIV testing rates improved from 67.4% at baseline to 94% in the tuberculosis clinic. HCV testing was added to all individuals in the dermatovenerology clinic, eight patients of 1701 tested positive (0.47%). HBV testing was added to individuals with sexually transmitted infections with a 0.44% positivity rate (2/452 tested positive). The Indicator condition guided HIV testing strategy was expanded to offer HIV/HCV testing to people with alcohol dependency and chemsex-users. 52% of chemsex-users tested positive for ≥ 1 sexually transmitted infection and among people with alcohol dependency 0.3 and 3.7% tested positive for HIV and HCV respectively.

conclusionsThe four pilot studies successfully increased integrated testing in health care settings, by introducing testing for HBV/HCV and sexually transmitted infections along with HIV testing for established indicator conditions and expanding the strategy to include new indicators; alcohol dependency and chemsex. HCV testing of individuals with alcohol abuse showed high positivity rates and calls for further implementation studies. Methods used for implementing indicator condition guided HIV Testing have proven transferable to implementation of integrated testing.

Indexed as

Hepatitis CHIV InfectionsSexually Transmitted DiseasesAmbulatory Care FacilitiesDelivery of Health CareHumansLithuaniaRetrospective StudiesRomaniaSpainHIVIntegrated testingSexually transmitted infectionsViral hepatitis

Identifiers

PMID34517830
PMCPMC8438813
OpenAlexW3200165158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.